Diampa LXR 10+5+1000mg Tablet – Once-Daily Ultimate Triple Assault on High HbA1c & Cardio-Renal Risk
Diampa LXR 10+5+1000mg Tablet – Once-Daily Ultimate Triple Assault on High HbA1c & Cardio-Renal Risk
Diampa LXR 10+5+1000mg Tablet – Once-Daily Ultimate Triple Assault on High HbA1c & Cardio-Renal Risk
Description
Diampa LXR 10+5+1000mg Tablet – Dapagliflozin 10mg + Linagliptin 5mg + Metformin XR 1000mg Most Advanced Single-Pill Triple Therapy
Diampa LXR 10+5+1000mg is the highest-strength once-daily triple combination ever launched: full-dose SGLT2 inhibitor (Dapagliflozin 10mg) + full-dose DPP-4 inhibitor (Linagliptin 5mg) + maximum extended-release Metformin 1000mg. One morning tablet delivers a massive 2.1–2.8% HbA1c drop, 4–7 kg weight loss, 5–7 mmHg systolic BP reduction, and the strongest available cardio-renal protection (up to 40% fewer heart-failure events & 46% slower kidney decline). This is the final oral step for patients with HbA1c >9%, established CVD, or diabetic kidney disease who need everything in one pill.
